Cytokeratin 13 (KRT13) antibody

Antigen: Cytokeratin 13 (KRT13)

Synonyms: K13, CK13, MGC3781, MGC161462, Krt1-13, Krt-1.13

Clonality: Monoclonal (Ks13-1)

Host: Mouse

Reactivity: Human, Cow (Bovine), Rat (Rattus)

Application: Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Catalog no.: ABIN93716

Additional Information

Alternative name: Cytokeratin 13

Immunogen: Human purified Cytokeratin 13

Format: Ready to use

Isotype: IgG1  (Matching secondary antibodies)

Clone: Ks13-1

Description: Antibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide**. The volume is sufficient for at least 50 immunohistochemical tests (100 ul working solution / test). Use appropriate antibody diluent.

Specificity: Acid Cytokeratin 13, 54 kD, pI 5.1

Application Details

Application Notes: C, P , Improvement of staining with Unmasking Fluid G neat Positive Control: Urothelial carcinoma

Buffer: Antibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide. The volume is sufficient for at least 50 immunohistochemical tests (100 ul working solution / test)

Storage: 2-8°C

Research Area: Extracellular Matrix

Restrictions: For Research Use only

Images

Urothelial tissue stained with anti-Cytokeratin 13

Publications

Publications: Moll, Franke, Schiller et al.: "The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells." in: Cell, Vol. 31, Issue 1, pp. 11-24, 1983 (PubMed).

Gown, Vogel: "Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues." in: The American journal of pathology, Vol. 114, Issue 2, pp. 309-21, 1984 (PubMed).

Yang XJ, Lecksell K, Gaudin P et al.: "Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer." in: Am J Surg Pathol, Vol. 23, Issue 2, pp. 147-52, 1999 (PubMed).